EFFECT OF FAMOTIDINE ON THEOPHYLLINE PHARMACOKINETICS IN THE RAT

被引：3

作者：

ALHASSAN, MI

BAWAZIR, SA

MATAR, KM

TEKLE, A

机构：

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1989年 / 50卷 / 01期

关键词：

D O I：

10.1016/0378-5173(89)90178-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：35 / 38

页数：4

共 13 条

[1]

CARPENTER P, 1985, ADOLESCENCE, V20, P599

[2]

CHERMOS AN, 1986, CLIN PHARMACOL THER, V39, P187

[3]

GARG D C, 1982, Clinical Pharmacology and Therapeutics, V31, P228

[4] FAMOTIDINE - A NOTABLE LACK OF DRUG-INTERACTIONS [J].

HUMPHRIES, TJ .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 :55-60

[5] FAMOTIDINE, A NEW H2-RECEPTOR ANTAGONIST, DOES NOT AFFECT HEPATIC ELIMINATION OF DIAZEPAM OR TUBULAR SECRETION OF PROCAINAMIDE [J].

KLOTZ, U ;

ARVELA, P ;

ROSENKRANZ, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (06) :671-675

[6]

KNODELL RG, 1982, GASTROENTEROLOGY, V82, P84

[7] RECENT ADVANCES IN PHARMACEUTICAL CHEMISTRY .2. HISTAMINE H-2-RECEPTOR ANTAGONISTS [J].

LEE, RM ;

MCDOWALL, RD .

JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1986, 11 (06) :389-408

[8] INTERACTION OF DIAZEPAM WITH FAMOTIDINE AND CIMETIDINE, 2 H-2-RECEPTOR ANTAGONISTS [J].

LOCNISKAR, A ;

GREENBLATT, DJ ;

HARMATZ, JS ;

ZINNY, MA ;

SHADER, RI .

JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (04) :299-303

[9]

POWELL JR, 1984, AM J MED, V77, P57

[10]

RENDIC S, 1983, DRUG METAB DISPOS, V11, P137

← 1 2 →